Guggenheim Maintains Buy on Veracyte, Lowers Price Target to $45
Benzinga Newsdesk 7 months ago
NewsPrice TargetAnalyst Ratings
Guggenheim analyst Subbu Nambi maintains Veracyte (NASDAQ:VCYT) with a Buy and lowers the price target from $50 to $45.
Guggenheim analyst Subbu Nambi maintains Veracyte (NASDAQ:VCYT) with a Buy and lowers the price target from $50 to $45.